Novel Compounds as ARNT Degraders for Treating Cancer, in Particular, Hematological Cancer

Provided herein are novel compounds as ARNT degraders, pharmaceutical compositions, use of such compounds in treating cancer, in particular, hematological cancer, and processes for preparing such compounds.

Authors

Ram W. Sabnis (ORCID: https://orcid.org/0000-0001-7289-0581)

Publication Details

Journal: ACS Medicinal Chemistry Letters
Published: 2026-01-05
DOI: https://doi.org/10.1021/acsmedchemlett.5c00777
Primary Topic: Electron Spin Resonance Studies
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Novel Compounds as ARNT Degraders for Treating Cancer, in Particular, Hematological Cancer

Ram W. Sabnis

Jan 5, 2026

ACS Medicinal Chemistry Letters

Electron Spin Resonance Studies

article

Novel Compounds as ARNT Degraders for Treating Cancer, in Particular, Hematological Cancer

Ram W. Sabnis

January 5, 2026article en

Abstract

ACS Medicinal Chemistry LettersVol. 17(2)

Openalex Percentile: Top 98%

Electron Spin Resonance Studies

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Novel Compounds as ARNT Degraders for Treating Cancer, in Particular, Hematological Cancer — Ram W. Sabnis · ACS Medicinal Chemistry Letters (2026) | TGRS Research Map | TGRS